The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Therapeutic Drug Monitoring Test Market Research Report 2025

Global Therapeutic Drug Monitoring Test Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1694258

No of Pages : 89

Synopsis
Global Therapeutic Drug Monitoring Test market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Therapeutic Drug Monitoring Test market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Therapeutic Drug Monitoring Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson
Quest Diagnostics
Segment by Type
Blood Test
Urine Test
Saliva Test
Other Test
Segment by Application
Hospital Labs
Private Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Therapeutic Drug Monitoring Test report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Drug Monitoring Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.2.5 Other Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Labs
1.3.3 Private Labs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Drug Monitoring Test Market Perspective (2018-2029)
2.2 Therapeutic Drug Monitoring Test Growth Trends by Region
2.2.1 Global Therapeutic Drug Monitoring Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Drug Monitoring Test Historic Market Size by Region (2018-2023)
2.2.3 Therapeutic Drug Monitoring Test Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Drug Monitoring Test Market Dynamics
2.3.1 Therapeutic Drug Monitoring Test Industry Trends
2.3.2 Therapeutic Drug Monitoring Test Market Drivers
2.3.3 Therapeutic Drug Monitoring Test Market Challenges
2.3.4 Therapeutic Drug Monitoring Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Drug Monitoring Test Players by Revenue
3.1.1 Global Top Therapeutic Drug Monitoring Test Players by Revenue (2018-2023)
3.1.2 Global Therapeutic Drug Monitoring Test Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Drug Monitoring Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Drug Monitoring Test Revenue
3.4 Global Therapeutic Drug Monitoring Test Market Concentration Ratio
3.4.1 Global Therapeutic Drug Monitoring Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring Test Revenue in 2022
3.5 Therapeutic Drug Monitoring Test Key Players Head office and Area Served
3.6 Key Players Therapeutic Drug Monitoring Test Product Solution and Service
3.7 Date of Enter into Therapeutic Drug Monitoring Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Drug Monitoring Test Breakdown Data by Type
4.1 Global Therapeutic Drug Monitoring Test Historic Market Size by Type (2018-2023)
4.2 Global Therapeutic Drug Monitoring Test Forecasted Market Size by Type (2024-2029)
5 Therapeutic Drug Monitoring Test Breakdown Data by Application
5.1 Global Therapeutic Drug Monitoring Test Historic Market Size by Application (2018-2023)
5.2 Global Therapeutic Drug Monitoring Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Drug Monitoring Test Market Size (2018-2029)
6.2 North America Therapeutic Drug Monitoring Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Therapeutic Drug Monitoring Test Market Size by Country (2018-2023)
6.4 North America Therapeutic Drug Monitoring Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Drug Monitoring Test Market Size (2018-2029)
7.2 Europe Therapeutic Drug Monitoring Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Therapeutic Drug Monitoring Test Market Size by Country (2018-2023)
7.4 Europe Therapeutic Drug Monitoring Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring Test Market Size (2018-2029)
8.2 Asia-Pacific Therapeutic Drug Monitoring Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Therapeutic Drug Monitoring Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Drug Monitoring Test Market Size (2018-2029)
9.2 Latin America Therapeutic Drug Monitoring Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Therapeutic Drug Monitoring Test Market Size by Country (2018-2023)
9.4 Latin America Therapeutic Drug Monitoring Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring Test Market Size (2018-2029)
10.2 Middle East & Africa Therapeutic Drug Monitoring Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Therapeutic Drug Monitoring Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Therapeutic Drug Monitoring Test Introduction
11.1.4 Roche Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Therapeutic Drug Monitoring Test Introduction
11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.2.5 Danaher Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Therapeutic Drug Monitoring Test Introduction
11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Test Introduction
11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Therapeutic Drug Monitoring Test Introduction
11.5.4 Siemens Healthcare Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.5.5 Siemens Healthcare Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Test Introduction
11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Therapeutic Drug Monitoring Test Introduction
11.7.4 BioMerieux Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.7.5 BioMerieux Recent Development
11.8 Sanquin
11.8.1 Sanquin Company Detail
11.8.2 Sanquin Business Overview
11.8.3 Sanquin Therapeutic Drug Monitoring Test Introduction
11.8.4 Sanquin Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.8.5 Sanquin Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Detail
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson Therapeutic Drug Monitoring Test Introduction
11.9.4 Becton Dickinson Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.9.5 Becton Dickinson Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Therapeutic Drug Monitoring Test Introduction
11.10.4 Quest Diagnostics Revenue in Therapeutic Drug Monitoring Test Business (2018-2023)
11.10.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’